Eric Crombez

Board Director

Director

Abeona Therapeutics Inc.Ultragenyx Pharmaceutical Inc.

Insider activity · 24 months0 buys4 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 1 saleMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 1 saleSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 1 saleMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 1 saleJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (10 ops.)

€828k

Latest filing published 15 May 2026 for Abeona Therapeutics INC., €124k.

Filing timeline

BuySale

Eric Crombez

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Eric Crombez: trading record in brief

Eric Crombez (board member) discloses dealings in 2 companies, chiefly Ultragenyx Pharmaceutical Inc. and Abeona Therapeutics Inc. Between 1 May 2023 and 15 May 2026, the trades on record add up to 19 filings.

On the market, this insider has only sold: 10 sales, €828k in total. Outside the open market, there are 9 share grants. So far in 2026, the count stands at no purchases and 3 sales.

The newest entry dates from 15 May 2026: an open-market sale of €124k, in Abeona Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.